Výsledky vyhledávání - Clifton‐Hadley, Laura
- Zobrazuji výsledky 1 - 20 z 20
-
1
Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme Autor Megias, Daniel, Phillips, Mark, Clifton-Hadley, Laura, Harron, Elizabeth, Eaton, David J, Sanghera, Paul, Whitfield, Gillian
Vydáno 2017Text -
2
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgki... Autor Cutter, David J., Ramroth, Johanna, Diez, Patricia, Buckle, Andy, Ntentas, Georgios, Popova, Bilyana, Clifton-Hadley, Laura, Hoskin, Peter J., Darby, Sarah C., Radford, John, Illidge, Tim
Vydáno 2021Text -
3
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including (18)F-FDG-... Autor Latifoltojar, Arash, Punwani, Shonit, Lopes, Andre, Humphries, Paul D., Klusmann, Maria, Menezes, Leon Jonathan, Daw, Stephen, Shankar, Ananth, Neriman, Deena, Fitzke, Heather, Clifton-Hadley, Laura, Smith, Paul, Taylor, Stuart A.
Vydáno 2018Text -
4
Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRU... Autor Townsend, William, Leong, Sarah, Hoskin, Peter, Diez, Patricia, Patrick, Pip, Linch, David, Wong, Wai‐Lup, Kayani, Irfan, Sanghera, Bal, Lopes, Andre, Daw, Stephen, Collins, Graham, Clifton‐Hadley, Laura, Ardeshna, Kirit
Vydáno 2019Text -
5
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma Autor Brown, Nicholas, McBain, Catherine, Nash, Stephen, Hopkins, Kirsten, Sanghera, Paul, Saran, Frank, Phillips, Mark, Dungey, Fiona, Clifton-Hadley, Laura, Wanek, Katharina, Krell, Daniel, Jeffries, Sarah, Khan, Iftekhar, Smith, Paul, Mulholland, Paul
Vydáno 2016Text -
6
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma Autor Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John
Vydáno 2020Text -
7
Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial Autor Phillips, Elizabeth H., Burton, Catherine, Kirkwood, Amy A., Barrans, Sharon, Lawrie, Anthony, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Ardeshna, Kirit M., Montoto, Silvia, Paneesha, Shankara, Clifton‐Hadley, Laura, Linch, David C., McMillan, Andrew K.
Vydáno 2020Text -
8
Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial Autor Anderson, Richard A, Remedios, Rachel, Kirkwood, Amy A, Patrick, Pip, Stevens, Linsey, Clifton-Hadley, Laura, Roberts, Tom, Hatton, Chris, Kalakonda, Nagesh, Milligan, Don W, McKay, Pam, Rowntree, Clare, Scott, Fiona M, Johnson, Peter W M
Vydáno 2018Text -
9
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study Autor Barrington, Sally F., Phillips, Elizabeth H., Counsell, Nicholas, Hancock, Barry, Pettengell, Ruth, Johnson, Peter, Townsend, William, Culligan, Dominic, Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, O’Doherty, Michael J., Illidge, Tim, Radford, John
Vydáno 2019Text -
10
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial Autor Brazil, Lucy, Swampillai, Angela L, Mak, Ka Man, Edwards, Darren, Mesiri, Pavlina, Clifton-Hadley, Laura, Shaffer, Richard, Lewis, Joanne, Watts, Colin, Jeffries, Sarah, Gkogkou, Pinelopi, Chalmers, Anthony J, Fersht, Naomi L, Hackshaw, Allan, Short, Susan C
Vydáno 2020Text -
11
COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial Autor Camilleri, Marquita, Sive, Jonathan, Wilson, William, Pang, Gavin, Jenner, Richard, Phillips, Elizabeth, Popat, Rakesh, Ramasamy, Karthik, Bygrave, Ceri, Dadaga, Tushhar, Streetly, Matthew, Cavenagh, James, Chapman, Mike, Barrington, Sally, Pike, Lucy, Owen, Roger, Clifton‐Hadley, Laura, Yong, Kwee
Vydáno 2020Text -
12
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation Autor Hough, Rachael, Lopes, Andre, Patrick, Pip, Russell, Nigel, Raj, Kavita, Tholouli, Eleni, A. Snowden, John, Collin, Matthew, El-Mehidi, Nadjet, Lawrie, Anthony, Clifton-Hadley, Laura, Veys, Paul, Craddock, Charles, Mackinnon, Stephen, Cook, Gordon, Shaw, Bronwen, Marks, David
Vydáno 2022Text -
13
Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study Autor Das-Gupta, Emma, Thomson, Kirsty J., Bloor, Adrian J. C., Clark, Andrew D., Mackinnon, Stephen, Kayani, Irfan, Clifton-Hadley, Laura, Patrick, Pip, El-Mehidi, Nadjet, Lawrie, Anthony, Kirkwood, Amy A., Russell, Nigel H., Linch, David C., Peggs, Karl S.
Vydáno 2019Text -
14
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: result... Autor Marks, David I, Clifton-Hadley, Laura, Copland, Mhairi, Hussain, Jiaull, Menne, Tobias F, McMillan, Andrew, Moorman, Anthony V, Morley, Nicholas, Okasha, Dina, Patel, Bela, Patrick, Pip, Potter, Michael N, Rowntree, Clare J, Kirkwood, Amy A, Fielding, Adele K
Vydáno 2022Text -
15
An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma Autor Watts, Colin, Ashkan, Keyoumars, Jenkinson, Michael D., Price, Stephen J., Santarius, Thomas, Matys, Tomasz, Zhang, Ting Ting, Finch, Alina, Collins, Peter, Allinson, Kieren, Jefferies, Sarah J., Scoffings, Daniel J., Zisakis, Athanasios, Phillips, Mark, Wanek, Katharina, Smith, Paul, Clifton-Hadley, Laura, Counsell, Nicholas
Vydáno 2021Text -
16
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial Autor Mitchell, Rachel J., Kirkwood, Amy A., Barretta, Emilio, Clifton-Hadley, Laura, Lawrie, Emma, Lee, SooWah, Leongamornlert, Daniel, Marks, David I., McMillan, Andrew K., Menne, Tobias F., Papaemmanuil, Elli, Patel, Bela, Patrick, Pip, Rowntree, Clare J., Zareian, Nahid, Alapi, Krisztina Zuborne, Moorman, Anthony V., Fielding, Adele K.
Vydáno 2021Text -
17
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study Autor Moorman, Anthony V., Barretta, Emilio, Butler, Ellie R., Ward, Eleanor J., Twentyman, Katie, Kirkwood, Amy A., Enshaei, Amir, Schwab, Claire, Creasey, Tom, Leongamornlert, Daniel, Papaemmanuil, Elli, Patrick, Pip, Clifton-Hadley, Laura, Patel, Bela, Menne, Tobias, McMillan, Andrew K., Harrison, Christine J., Rowntree, Clare J., Marks, David I., Fielding, Adele K.
Vydáno 2021Text -
18
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Autor Roddie, Claire, Dias, Juliana, O'Reilly, Maeve A., Abbasian, Mahnaz, Cadinanos-Garai, Amaia, Vispute, Ketki, Bosshard-Carter, Leticia, Mitsikakou, Marina, Mehra, Vedika, Roddy, Harriet, Hartley, John A., Spanswick, Victoria, Lowe, Helen, Popova, Bilyana, Clifton-Hadley, Laura, Wheeler, Graham, Olejnik, Joanna, Bloor, Adrian, Irvine, David, Wood, Leigh, Marzolini, Maria A. V., Domning, Sabine, Farzaneh, Farzin, Lowdell, Mark W., Linch, David C., Pule, Martin A., Peggs, Karl S.
Vydáno 2021Text -
19
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature Autor Chapman, Michael A., Sive, Jonathan, Ambrose, John, Roddie, Claire, Counsell, Nicholas, Lach, Anna, Abbasian, Mahnaz, Popat, Rakesh, Cavenagh, Jamie D., Oakervee, Heather, Streetly, Matthew J., Schey, Stephen, Koh, Mickey, Willis, Fenella, Virchis, Andres E., Crowe, Josephine, Quinn, Michael F., Cook, Gordon, Crawley, Charles R., Pratt, Guy, Cook, Mark, Braganza, Nivette, Adedayo, Toyin, Smith, Paul, Clifton-Hadley, Laura, Owen, Roger G., Sonneveld, Pieter, Keats, Jonathan J., Herrero, Javier, Yong, Kwee
Vydáno 2018Text -
20
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, rand... Autor Marks, David I, Kirkwood, Amy A, Rowntree, Clare J, Aguiar, Melanie, Bailey, Katharine E, Beaton, Brendan, Cahalin, Paul, Castleton, Anna Z, Clifton-Hadley, Laura, Copland, Mhairi, Goldstone, Anthony H, Kelly, Richard, Lawrie, Emma, Lee, SooWah, McMillan, Andrew K, McMullin, Mary Frances, Menne, Tobias F, Mitchell, Rachel J, Moorman, Anthony V, Patel, Bela, Patrick, Pip, Smith, Paul, Taussig, David, Yallop, Deborah, Alapi, Krisztina Zuborne, Fielding, Adele K
Vydáno 2022Text